Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
14 Leser
Artikel bewerten:
(0)

MediQuip Holdings, Inc. Announces a Significant Enhancement in Operating Results Over the Last Quarter


LONDON, July 7 /PRNewswire-FirstCall/ -- MediQuip Holdings, Inc., (BULLETIN BOARD: MQPH) A specialist in medical pressure relieving equipment is pleased to announce an increase of 33% for its operating results for the quarter ended April 30, 2006.

MediQuip Holdings today announced an increase in its operating results by 33.1%, an improvement in deficit to $46,243 for the first quarter in the current fiscal year compared with a deficit of $69,112 for the same period last year. The improvement in operating results by 98% when compared with the results for the previous year ended January 31, 2006 represents a significant enhancement in earnings.

"I am very pleased to announce this significant improvement in our operating results" David Francis, the Chief Executive Officer and President of MEDIQUIP HOLDINGS, INC., stated. "We continue to work hard to improve our results by striving to deliver the best service in the sector. We are committed to taking full advantage of the considerable upside potential in our market. We fully expect to benefit from further growth and profitability to enhance shareholder value moving forward from this point."

About MEDIQUIP HOLDINGS,

MediQuip Holdings, http://www.westmeria.com/ is a full service specialist, medical equipment supplier to the healthcare industry. Its primary clients are Great Britain's National Health Service (NHS), private hospitals and the private Nursing Home Industry. Its core business is supplying proprietary branded specialist pressure relieving equipment for the healthcare sector. The branded products are manufactured and licensed for the company in Germany, Belgium and Taiwan.

The statements contained in this news release that are not historical facts may be statements regarding the Company's future that involve risks and uncertainties which could cause actual results to differ materially from those currently anticipated. For example, statements that describe the Company's hopes, plans, objectives, goals, intentions or expectations are all forward looking statements. Any such statements made herein about the Company's future are only made as of the date of this news release. Numerous factors, many of which are beyond the Company's control, may affect actual results. The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact: David Francis + (44) 208 658 9575

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2006 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.